Which pharmaceutical company was first to develop and market a recombinant human insulin product, revolutionizing diabetes treatment?

In the pharmaceutical and medical device industries, product development follows rigorous protocols to ensure safety and efficacy. The journey from concept to market involves multiple phases of testing, regulatory approval processes, and strategic marketing decisions. This poll tests your knowledge about a significant historical medical product development milestone that changed treatment paradigms.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Eli Lilly (with product Humulin, 1982)
Novo Nordisk (with product Novolin, 1991)
Sanofi (with product Lantus, 1996)
Pfizer (with product Exubera, 2001)